KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) FCF Margin (2016 - 2026)

Medtronic's FCF Margin history spans 13 years, with the latest figure at 25.51% for Q1 2026.

  • For Q1 2026, FCF Margin rose 23.0% year-over-year to 25.51%; the TTM value through Jan 2026 reached 15.25%, down 122.0%, while the annual FY2025 figure was 15.46%, 61.0% down from the prior year.
  • FCF Margin for Q1 2026 was 25.51% at Medtronic, up from 5.1% in the prior quarter.
  • Across five years, FCF Margin topped out at 27.37% in Q2 2024 and bottomed at 2.51% in Q4 2023.
  • The 5-year median for FCF Margin is 16.07% (2023), against an average of 15.51%.
  • The largest annual shift saw FCF Margin crashed -1119bps in 2022 before it soared 1023bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 7.9% in 2022, then crashed by -68bps to 2.51% in 2023, then soared by 163bps to 6.59% in 2024, then dropped by -23bps to 5.1% in 2025, then skyrocketed by 400bps to 25.51% in 2026.
  • Per Business Quant, the three most recent readings for MDT's FCF Margin are 25.51% (Q1 2026), 5.1% (Q4 2025), and 6.81% (Q3 2025).